HU Xiao-yun, CHEN Jin-zhang, WANG Sen-rui. Efficacy Comparison Between Atezolizumab Plus Bevacizumab and Sorafenib in Unresectable Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2021, 21(6): 325-328. DOI: 10.12019/j.issn.1671-5144.2021.06.002
Citation:
|
HU Xiao-yun, CHEN Jin-zhang, WANG Sen-rui. Efficacy Comparison Between Atezolizumab Plus Bevacizumab and Sorafenib in Unresectable Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2021, 21(6): 325-328. DOI: 10.12019/j.issn.1671-5144.2021.06.002
|
HU Xiao-yun, CHEN Jin-zhang, WANG Sen-rui. Efficacy Comparison Between Atezolizumab Plus Bevacizumab and Sorafenib in Unresectable Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2021, 21(6): 325-328. DOI: 10.12019/j.issn.1671-5144.2021.06.002
Citation:
|
HU Xiao-yun, CHEN Jin-zhang, WANG Sen-rui. Efficacy Comparison Between Atezolizumab Plus Bevacizumab and Sorafenib in Unresectable Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2021, 21(6): 325-328. DOI: 10.12019/j.issn.1671-5144.2021.06.002
|